Zhuoya Li Selected Research

Neoplasms (Cancer)

1/2023	Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers.
1/2021	The Road of Solid Tumor Survival: From Drug-Induced Endoplasmic Reticulum Stress to Drug Resistance.
1/2021	Suppression of Transmembrane Tumor Necrosis Factor Alpha Processing by a Specific Antibody Protects Against Colitis-Associated Cancer.
9/2020	Effects of aspirin on the gastrointestinal tract: Pros vs. cons.
1/2019	Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression.
1/2019	Circular RNAs: an emerging landscape in tumor metastasis.
1/2018	Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells.
3/2017	Transmembrane tumor necrosis factor-α promotes the recruitment of MDSCs to tumor tissue by upregulating CXCR4 expression via TNFR2.
1/2017	Tumor necrosis factor α in the onset and progression of leukemia.
1/2017	STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhuoya Li Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 01/2002
7	Infections 06/2023 - 09/2010
3	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2009
3	Hypertrophy 12/2020 - 06/2008
3	Weight Loss (Weight Reduction) 04/2011 - 12/2006
2	Colitis 01/2021 - 04/2011
2	Fibrosis (Cirrhosis) 01/2021 - 12/2020
2	Inflammation (Inflammations) 12/2020 - 10/2018
2	Septic Shock (Toxic Shock Syndrome) 01/2019 - 12/2002
2	Carcinogenesis 01/2019 - 02/2007
2	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2006
2	Leukemia 01/2017 - 09/2015
2	Necrosis 10/2009 - 09/2008
2	Carcinoma (Carcinomatosis) 12/2006 - 01/2003
1	Astigmatism 01/2023
1	Cataract (Cataracts) 01/2023
1	Poisoning 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Uveal melanoma 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Colitis-Associated Neoplasms 01/2021
1	Cardiomegaly (Heart Hypertrophy) 12/2020
1	Heart Failure 12/2020
1	Hemorrhage 09/2020
1	Ulcer 09/2020
1	Adenocarcinoma of Lung 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Chronic Granulomatous Disease 01/2019

Drug/Important Bio-Agent (IBA)

16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2002
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2003
3	Phosphotransferases (Kinase)IBA 01/2023 - 01/2019
3	Type I Tumor Necrosis Factor ReceptorsIBA 12/2020 - 06/2008
3	Messenger RNA (mRNA)IBA 09/2013 - 01/2003
2	Monoclonal AntibodiesIBA 01/2023 - 09/2015
2	InterleukinsIBA 01/2023 - 01/2019
2	Dextrans (Dextran)FDA Link 01/2021 - 01/2019
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021 - 01/2019
2	Transaminases (Aminotransferases)IBA 01/2021 - 02/2016
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2020 - 10/2018
2	CytokinesIBA 12/2020 - 02/2016
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2020 - 06/2008
2	EnzymesIBA 12/2020 - 09/2013
2	Type II Tumor Necrosis Factor ReceptorsIBA 12/2020 - 03/2017
2	LipopolysaccharidesIBA 01/2019 - 02/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2019
2	Tumor Necrosis Factor InhibitorsIBA 01/2017 - 07/2013
2	NF-kappa B (NF-kB)IBA 07/2009 - 09/2008
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	AmanitinsIBA 01/2023
1	Carbofuran (Furadan)IBA 01/2023
1	bromadioloneIBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	PhytochemicalsIBA 01/2021
1	flavoneIBA 01/2021
1	NucleotidesIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021
1	AcidsIBA 01/2021
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	CateninsIBA 01/2021
1	SilymarinIBA 01/2021
1	CarbohydratesIBA 01/2021
1	AzoxymethaneIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2020
1	Macrophage Colony-Stimulating FactorIBA 01/2019
1	Adenosine Triphosphatases (ATPase)IBA 01/2019
1	R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA 01/2019
1	SNARE Proteins (SNAREs)IBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	InflammasomesIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 01/2019
1	Cathepsin BIBA 01/2019
1	Circular RNAIBA 01/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Caspase 1 (ICE Protease)IBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2019
1	Lysosomal-Associated Membrane Protein 1IBA 01/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Qa-SNARE Proteins (Syntaxin)IBA 01/2019
1	3-methyladenineIBA 01/2019
1	InterferonsIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	AnthracyclinesIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2023 - 09/2015
3	Drug Therapy (Chemotherapy) 01/2018 - 09/2015
1	Kidney Transplantation 06/2023
1	Intraocular Lenses (Intraocular Lens) 01/2023
1	Punctures 01/2019
1	Ligation 01/2019